This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (117)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Richard J. Haskell, MD; Bryan M. Wong, MD; James E. Hansen, MD

Arch Intern Med. 1983;143(7):1324-1327.

Abstract
• Twenty-five consecutive patients admitted with status asthmaticus were blindly randomized to receive intravenous (IV) methylprednisolone every six hours for three days at one of the following dosages: (1) low, 15 mg; (2) medium, 40 mg; or (3) high, 125 mg. All other therapy, including IV and inhaled bronchodilators, was kept constant. We measured forced expiratory volume in 1 s (FEV₁) to quantitate response. The high-dose group improved significantly by the end of the first day, the medium-dose group improved by the middle of the second day, but the low-dose group did not improve significantly in three days. Together, the high- and medium-dose groups were significantly improved (FEV₁ >50% of predicted) compared with the low-dose group. No serious steroid side effects were encountered. We conclude that the greater benefit of higher doses of steroids, such as 125 mg of methylprednisolone every six hours, justifies their use in severe asthma.

(Arch Intern Med 1983;143:1324-1327)

Author Affiliations
From the Division of Respiratory Physiology and Medicine, Los Angeles County Harbor—UCLA Medical Center and the UCLA School of Medicine, Torrance.

Footnotes
Accepted for publication Feb 28, 1983.

Presented in part at the 47th Annual Scientific Assembly of the American College of Chest Physicians, San Francisco, Oct 28,1981.

Reprint requests to Division of Respiratory Physiology and Medicine, Los Angeles County Harbor—UCLA Medical Center, Torrance, CA 90509 (Dr Hansen).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Efficacy of Budesonide or Montelukast Treatment of Wheezing Preschoolers
Weinberger
AAP Grand Rounds 2009;21:43-43.
FULL TEXT  

Oral vs Inhaled Corticosteroids Following Emergency Department Discharge of Patients With Acute Asthma
Marik and Varon
Chest 2002;121:1735-1736.
FULL TEXT  

Corticosteroids in Acute Respiratory Failure
JANTZ and SAHN
Am. J. Respir. Crit. Care Med. 1999;160:1079-1100.
FULL TEXT  

Corticosteroids in the Emergency Department Therapy of Acute Adult Asthma: An Evidence-Based Evaluation
Rodrigo and Rodrigo
Chest 1999;116:285-295.
ABSTRACT | FULL TEXT  

Myopathy Following Mechanical Ventilation for Acute Severe Asthma: The Role of Muscle Relaxants and Corticosteroids
Awadh Behbehani et al.
Chest 1999;115:1627-1631.
ABSTRACT | FULL TEXT  

Pharmacotherapy for Asthma and Chronic Obstructive Pulmonary Disease: Current Thinking, Practices, and Controversies
Skorodin
Arch Intern Med 1993;153:814-828.
ABSTRACT  

Early Administration of Corticosteroids in Emergency Room Treatment of Acute Asthma
Stein and Cole
ANN INTERN MED 1990;112:822-827.
ABSTRACT  

Status Asthmaticus
Jederlinic and Irwin
J Intensive Care Med 1989;4:166-184.
 

Are Intravenous Corticosteroids Required in Status Asthmaticus?
Ratto et al.
JAMA 1988;260:527-529.
ABSTRACT  

Methylprednisolone in Status Asthmaticus
Rogol
Arch Intern Med 1984;144:1305-1305.
ABSTRACT